King D, Yeomanson D, Bryant HE (May 2015). "PI3King the lock: targeting the PI3K/Akt/mTOR pathway as a novel therapeutic strategy in neuroblastoma". Journal of Pediatric Hematology/Oncology. 37 (4): 245–51. doi:10.1097/MPH.0000000000000329. PMID25811750. S2CID42323379.
Peltier J, O'Neill A, Schaffer DV (September 2007). "PI3K/Akt and CREB regulate adult neural hippocampal progenitor proliferation and differentiation". Developmental Neurobiology. 67 (10): 1348–61. doi:10.1002/dneu.20506. PMID17638387. S2CID16337839.
Raphael J, Desautels D, Pritchard KI, Petkova E, Shah PS (March 2018). "Phosphoinositide 3-kinase inhibitors in advanced breast cancer: A systematic review and meta-analysis". European Journal of Cancer. 91: 38–46. doi:10.1016/j.ejca.2017.12.010. PMID29331750.
Costa RL, Han HS, Gradishar WJ (June 2018). "Targeting the PI3K/AKT/mTOR pathway in triple-negative breast cancer: a review". Breast Cancer Research and Treatment. 169 (3): 397–406. doi:10.1007/s10549-018-4697-y. PMID29417298. S2CID19888056.
Liu ST, Hui G, Mathis C, Chamie K, Pantuck AJ, Drakaki A (April 2018). "The Current Status and Future Role of the Phosphoinositide 3 Kinase/AKT Signaling Pathway in Urothelial Cancer: An Old Pathway in the New Immunotherapy Era". Clinical Genitourinary Cancer. 16 (2): e269–e276. doi:10.1016/j.clgc.2017.10.011. PMID29199023. S2CID4533538.
Park, Soonbum; Kim, Young Sik; Kim, Davis Yeon; So, Insuk; Jeon, Ju-Hong (December 2018). "PI3K pathway in prostate cancer: All resistant roads lead to PI3K". Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1870 (2): 198–206. doi:10.1016/j.bbcan.2018.09.001. ISSN1879-2561. PMID30300679. S2CID52947672.
King D, Yeomanson D, Bryant HE (May 2015). "PI3King the lock: targeting the PI3K/Akt/mTOR pathway as a novel therapeutic strategy in neuroblastoma". Journal of Pediatric Hematology/Oncology. 37 (4): 245–51. doi:10.1097/MPH.0000000000000329. PMID25811750. S2CID42323379.
Peltier J, O'Neill A, Schaffer DV (September 2007). "PI3K/Akt and CREB regulate adult neural hippocampal progenitor proliferation and differentiation". Developmental Neurobiology. 67 (10): 1348–61. doi:10.1002/dneu.20506. PMID17638387. S2CID16337839.
Raphael J, Desautels D, Pritchard KI, Petkova E, Shah PS (March 2018). "Phosphoinositide 3-kinase inhibitors in advanced breast cancer: A systematic review and meta-analysis". European Journal of Cancer. 91: 38–46. doi:10.1016/j.ejca.2017.12.010. PMID29331750.
Costa RL, Han HS, Gradishar WJ (June 2018). "Targeting the PI3K/AKT/mTOR pathway in triple-negative breast cancer: a review". Breast Cancer Research and Treatment. 169 (3): 397–406. doi:10.1007/s10549-018-4697-y. PMID29417298. S2CID19888056.
Liu ST, Hui G, Mathis C, Chamie K, Pantuck AJ, Drakaki A (April 2018). "The Current Status and Future Role of the Phosphoinositide 3 Kinase/AKT Signaling Pathway in Urothelial Cancer: An Old Pathway in the New Immunotherapy Era". Clinical Genitourinary Cancer. 16 (2): e269–e276. doi:10.1016/j.clgc.2017.10.011. PMID29199023. S2CID4533538.
Park, Soonbum; Kim, Young Sik; Kim, Davis Yeon; So, Insuk; Jeon, Ju-Hong (December 2018). "PI3K pathway in prostate cancer: All resistant roads lead to PI3K". Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1870 (2): 198–206. doi:10.1016/j.bbcan.2018.09.001. ISSN1879-2561. PMID30300679. S2CID52947672.
King D, Yeomanson D, Bryant HE (May 2015). "PI3King the lock: targeting the PI3K/Akt/mTOR pathway as a novel therapeutic strategy in neuroblastoma". Journal of Pediatric Hematology/Oncology. 37 (4): 245–51. doi:10.1097/MPH.0000000000000329. PMID25811750. S2CID42323379.
Peltier J, O'Neill A, Schaffer DV (September 2007). "PI3K/Akt and CREB regulate adult neural hippocampal progenitor proliferation and differentiation". Developmental Neurobiology. 67 (10): 1348–61. doi:10.1002/dneu.20506. PMID17638387. S2CID16337839.
Costa RL, Han HS, Gradishar WJ (June 2018). "Targeting the PI3K/AKT/mTOR pathway in triple-negative breast cancer: a review". Breast Cancer Research and Treatment. 169 (3): 397–406. doi:10.1007/s10549-018-4697-y. PMID29417298. S2CID19888056.
Liu ST, Hui G, Mathis C, Chamie K, Pantuck AJ, Drakaki A (April 2018). "The Current Status and Future Role of the Phosphoinositide 3 Kinase/AKT Signaling Pathway in Urothelial Cancer: An Old Pathway in the New Immunotherapy Era". Clinical Genitourinary Cancer. 16 (2): e269–e276. doi:10.1016/j.clgc.2017.10.011. PMID29199023. S2CID4533538.
Park, Soonbum; Kim, Young Sik; Kim, Davis Yeon; So, Insuk; Jeon, Ju-Hong (December 2018). "PI3K pathway in prostate cancer: All resistant roads lead to PI3K". Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1870 (2): 198–206. doi:10.1016/j.bbcan.2018.09.001. ISSN1879-2561. PMID30300679. S2CID52947672.
Park, Soonbum; Kim, Young Sik; Kim, Davis Yeon; So, Insuk; Jeon, Ju-Hong (December 2018). "PI3K pathway in prostate cancer: All resistant roads lead to PI3K". Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1870 (2): 198–206. doi:10.1016/j.bbcan.2018.09.001. ISSN1879-2561. PMID30300679. S2CID52947672.